Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
Bispecific T-cell Engaging Antibody Epcoritamab Elicits Deep and Durable Response in R/R LBCL
Leah Lawrence
Early MMR With TKI Therapy Not Necessary to Normalize Survival in Patients Over 60 With CML
Khylia Marshall
STASEY Study Confirms Safety of Emicizumab Prophylaxis in Hemophilia A With FVIII Inhibitors
By Khylia Marshall
Decitabine Yields Similar Survival Despite Superior Responses Versus HU in MP-CMML
Thomas R. Collins
Consensus Guidelines Outline Treatment of ITP Related to SARS-CoV-2 Infection, Vaccination
Leah Lawrence
Glofitamab Shows Durable Remissions in R/R DLBCL
Thomas R. Collins
Response High for Bispecific Antibody Talquetamab in MM
By Leah Lawrence
Lenalidomide-Associated Risk for SPMs Appear Isolated to MM
Low VWF Levels Linked With Lower CVD Risk
Hydroxyurea Adherence Linked With Better Clinical Outcomes in SCD
IDH Inhibitor Olutasidenib Active With or Without Azacitidine in IDH1-Mutated AML
Addition of Daratumumab to Standard Therapy Does Not Increase Cardiac Events in AL Amyloidosis
Small Percentage of aPL-Positive Patients Without Autoimmune Diseases Received Immunosuppression
GPRC5D: A New Target for CAR T-Cell Therapy in MM
Review Confirms Likely Short-Term Benefits of HU in SCD
Clinical Correlates and Prognostic Value of Low QRS Voltages in Cardiac Amyloidosis
Untreated Bleeds Add to Disease Burden in Hemophilia A
Phase I/II Study Results in 87% Overall Response Rate With Venetoclax, Azacitidine Combo in High-Risk MDS
Leah Lawrence
DOACs Linked to Higher Postoperative Bleeding Incidence Than Warfarin Without Bridging
Katie Robinson
“Smart Start” Targeted Therapy Before Chemotherapy Elicits 86% ORR in Newly Diagnosed DLBCL
Leah Lawrence

Advertisement

Connect with us:

CURRENT ISSUE
March 2023

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2023 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement